Anocca AB
556946-2384ActiveEngineering precision T-cell immunotherapies for hard-to-treat cancers.
Oversikt
- 100–199
- Ansatte
- 750–999t SEK
- Omsetning
- 2013
- Grunnlagt
Nøkkelbeslutningstakere
Jacob Michlewicz
Chief Financial Officer
Niclas Sandberg
Head of Quality Control
Mattias Persson
Head of Engineering
Mikael Blomqvist
Board Member
+34 flere kontakter i Funnelfeedr
Beskrivelse
Anocca AB is a fully integrated, clinical-stage biopharmaceutical company based in Sweden. The organization specializes in creating libraries of T-cell receptor-engineered T cell (TCR-T) therapies. Their core mission is to redefine the treatment landscape for solid tumors, as well as infectious and...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556946238401
Beslutningstakere
38 kontakter i FunnelfeedrJacob Michlewicz
Chief Financial Officer
Niclas Sandberg
Head of Quality Control
Mattias Persson
Head of Engineering
Mikael Blomqvist
Board Member
Martin Welschof
Board Member
Fredrik Hansson
Board Member
Sophie Blomqvist
Board Member
Mark Farmery
CDO
Christiane Hanke-Harloff
Board Member
Hans Stråberg
Chairman of the Board
Ragnar Lindqvist
Board Member
Luke Pase
Chief Technology Officer
Ryan Hill
Chief Information Officer
Zach Chia
VP Strategy & Business Development
Jan Lundberg
Board Member
Viktor Arnkil
Chief Operating Officer
Zahid Bashir
Chief Medical Officer
Reagan Jarvis
Chief Executive Officer, Scientific founder
Hugh Salter
Chief Scientific Officer
Niklas Sjökvist
Head of Production
Rehab Alnabhan
Clinical Science Lead
Mikael Pedin
HR Manager
Sheila Forsman
Director of Clinical Development
Malin Löfdahl
Director of GMP Operations
Dennis Ahlstedt
IT Manager
Athina Totomi
Platform Project Manager
Andre kontakter
Sergey Zelenin
Principal Scientist
Richard Samuelson
Lead Software Engineer
Shenqiu Wang
Senior Scientist
Hannes Uchtenhagen
Principal Scientist
+8 flere kontakter i Funnelfeedr
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrCuraCell TX AB
5 ansatteEuropean biotech developing personalized T-cell therapies for solid cancer tumors.
Alvotech Sweden AB
20–49 ansatteDeveloping and manufacturing affordable biosimilars to expand global medicine access.
Lokon Pharma AB
10–19 ansatteDeveloping novel gene engineering vectors for cancer immunotherapy.
Asgard Therapeutics AB
10–19 ansattePioneering in vivo cell reprogramming for next-generation cancer immunotherapy.
Valo Therapeutics Oy
Developing novel peptide-coated oncolytic virus immunotherapies for cancer.
Utforsk mer
Spørsmål om Anocca AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo